Quest Diagnostics Boosts 2026 Guidance Amid Growth
Quest's Earnings Boost: A Closer Look There's no denying Quest Diagnostics (NYSE:DGX) has slipped into high gear this past quarter. Revenues for the third quarter landed at $3.10 billion—a tidy 10% lift from the previous year. With a reported diluted EPS of $2.78 jumping a whopping 28.7%, it's no wonder the folks at Quest decided to raise their guidance for the full...
Continue Reading